{"id":20853,"date":"2021-12-01T05:42:20","date_gmt":"2021-12-01T05:42:20","guid":{"rendered":"https:\/\/www.msdconnect.be\/fr\/?p=20853"},"modified":"2025-01-08T12:40:59","modified_gmt":"2025-01-08T12:40:59","slug":"the-older-cancer-patient-translating-recommendations-into-clinical-practice","status":"publish","type":"post","link":"https:\/\/www.msdconnect.be\/fr\/2021\/12\/01\/the-older-cancer-patient-translating-recommendations-into-clinical-practice\/","title":{"rendered":"The older cancer patient: translating recommendations into clinical practice"},"content":{"rendered":"\n
\"Old<\/figure>\n\n\n\n

MSD Belgium is delighted to invite you to our virtual symposium on the older patient with cancer that will take place on Wednesday 19th<\/sup> of January 2022<\/strong>, from 18h30-20h00<\/strong>. The live and interactive symposium is moderated by Prof. Dr. H. Wildiers and brought to you by a panel of Belgian experts in the field of oncogeriatry with the aim to support your daily management of the older cancer patient.<\/p>\n\n\n\n

The older cancer patient: translating recommendations into clinical practice<\/span><\/em><\/h3>\n\n\n\n

To register for the symposium please click here:<\/em><\/p>\n\n\n\n

\n
Register online<\/a><\/div>\n<\/div>\n\n\n\n
\n\t
\n\t\t\n\n

Virtual symposium<\/h4>\n\n\n\n

\"Icon\" Wednesday 19th of January 2022<\/p>\n\n\n\n

\"Icon\" 18h30-20h00<\/p>\n\n\n\n

Accreditation requested<\/p>\n\n\n\n

\"Icon\" Moderator: Prof. Dr. H. Wildiers (UZ Leuven)<\/p>\n\n\n\n

Presenters: Prof. Dr. L. Decoster (UZ Brussel),<\/p>\n\n\n\n

Dr. E. Naert (UZ Gent),<\/p>\n\n\n\n

Prof. Dr. L. Dal Lago (Institut Jules Bordet),<\/p>\n\n\n\n

Dr. V. Verschaeve (Grand H\u00f4pital de Charleroi)<\/p>\n\n\n\n

This virtual symposium is a non-promotional event organized by MSD Belgium in our commitment to contribute to continuous medical education. Attendance of the event is free of charge.<\/em><\/p>\n\n <\/div>\n<\/section>\n\n\n

Program<\/em> <\/th><\/th><\/tr><\/thead>
18h30-19h00<\/strong><\/td>Geriatric assessment: from theory and clinical trials into daily practice<\/td><\/tr>
18h30-18h50<\/strong><\/td>Not all older patients are the same, how can our understanding be improved? (Prof. Dr. L. Dal Lago)<\/td><\/tr>
18h50-19h00<\/strong><\/td>How to implement geriatric assessment into the daily practice: an ongoing challenge. (Dr. E. Naert)<\/td><\/tr>
19h00-20h00<\/strong><\/td>Cancer type specific guidelines: what do they mean for my patient?<\/td><\/tr>
19h00-19h20<\/strong><\/td>Early breast cancer (Prof. Dr. H. Wildiers)<\/td><\/tr>
19h20-19h40<\/strong><\/td>Immunotherapy in lung cancer (Prof. Dr. L. Decoster)<\/td><\/tr>
19h40-20h00<\/strong><\/td>Hormone therapies in prostate cancer (Dr. V. Verschaeve)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n

Each topic will be followed by a Q&A session to allow for an interactive discussion with the participants<\/p>\n\n\n\n

\n\t
\n\t\t\n\n